ABUS vs V
Arbutus Biopharma Corp (ABUS) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan McInerney.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the ABUS and V stock pages for the full models.
Not investment advice.